Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.25 | 7e-11 |
mRNA | VAMP3 | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-08 |
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-08 |
mRNA | PEA15 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-08 |
mRNA | TPD52L2 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
mRNA | HTRA1 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
mRNA | ITGB1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-07 |
mRNA | SBDS | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |